ArticleThe Lancet regional health. Western Pacific2026

Low-dose chidamide maintenance therapy following allogeneic hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia or lymphomas: a phase II, open-label, multicenter, single-arm trial.

Yanmin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.